| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/17/2006 | WO2006085697A1 Combination therapy for cerebrovascular disease using adrenomedulin with mesenchymal stem cell |
| 08/17/2006 | WO2006085692A1 Crystal of 4(3h)-quinazolinone derivative |
| 08/17/2006 | WO2006085612A1 Method for preparation of neural stem cells |
| 08/17/2006 | WO2006085607A1 Plant component-containing emulsion preparation and method for producing the same |
| 08/17/2006 | WO2006085562A1 Composition for preventing and/or treating metabolic syndrome and insulin resistance syndrome |
| 08/17/2006 | WO2006085417A1 Food for preventing life style-related diseases |
| 08/17/2006 | WO2006085112A1 Anthranilic acid derivatives as hm74a receptor agonists |
| 08/17/2006 | WO2006085108A1 Awthranilic acid derivatives and their use in treatment of diseases of lipid metabolism, in particular dyslipidaemia |
| 08/17/2006 | WO2006084761A1 Crystalline polymorphs of benazepril hydrochloride |
| 08/17/2006 | WO2006084757A2 Combination of ca/mg salt of valsartan with an antidiabetic agent |
| 08/17/2006 | WO2006084383A1 Anti-diabetic or anti-hypertensive dietary supplement |
| 08/17/2006 | WO2006084351A1 Anti-hypertensive dietary supplement derived from salmo or oncorhynchus protein hydrolysates |
| 08/17/2006 | WO2006084322A1 Treatment method for modifying tissue passive electrical conductance |
| 08/17/2006 | WO2006066599A3 Mas related g protein coupled receptors as drug targets |
| 08/17/2006 | WO2006063974A3 Il-15 antigen arrays and uses thereof |
| 08/17/2006 | WO2006061650A3 Methods, products and uses involving platelets and/or the vasculature |
| 08/17/2006 | WO2006060122A9 Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase |
| 08/17/2006 | WO2006046135A3 Pyrazolo[4,3-d] pyrimidine derivatives useful as pde-5 inhibitors |
| 08/17/2006 | WO2006044509A3 Methods of treating vascular injuries |
| 08/17/2006 | WO2006029182A3 Use of mdl-100,907 for treatment of allergic and eosinophil mediated diseases |
| 08/17/2006 | WO2005115422A3 Compositions containing avocado leaf extract for lowering cholesterol levels |
| 08/17/2006 | WO2003066071A8 Formulations comprising psychotropic drugs and selenium |
| 08/17/2006 | WO2003053346A3 Systems and methods for treating patients with processed lipoaspirate cells |
| 08/17/2006 | US20060183921 Pharmaceutically active compounds and methods of use |
| 08/17/2006 | US20060183805 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 08/17/2006 | US20060183797 Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 08/17/2006 | US20060183794 Drug composition containing nf-kb inhibitor |
| 08/17/2006 | US20060183784 Human growth hormone antagonists |
| 08/17/2006 | US20060183774 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
| 08/17/2006 | US20060183770 Sulfonamide derivative having isoxazole ring |
| 08/17/2006 | US20060183760 (2S3R)-3-{9-Isopropyl-6-[(pyridin-2-ylmethyl)-amino]-9H-purin-2-ylamino}-pentan-2-ol; treating proliferative disorders, viral disorders, CNS disorders, diabetes, stroke, alopecia or neurodegenerative; cancer, leukemia, psoriasis; cyclin-dependent kinase (CDK) inhibitors |
| 08/17/2006 | US20060183739 Carbonyl compounds |
| 08/17/2006 | US20060183734 (4-cyclohexyl-phenyl)-(4H, 10H-3a,5,9-triaza-benzo[f]azulen-9-yl)-methanone; antidiuretic, anticoagulant, diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, delay of urination, or bleeding |
| 08/17/2006 | US20060183713 Compositions of low molecular weight heparin produced with modified heparinase III |
| 08/17/2006 | US20060183695 Methods of increasing endogenous erythropoietin (EPO) |
| 08/17/2006 | US20060183680 Remedy for ischemia |
| 08/17/2006 | US20060183677 Novel exendin agonist formulations and methods of administration thereof |
| 08/17/2006 | US20060183665 Modulators of the potassium channels twik-1, task-1 gorl1. sk2 pr pcn1, used to treat arrhythmia, coronary heat disease or hypertension |
| 08/17/2006 | US20060183105 Human brain-derived tissue-specific potassium channel |
| 08/17/2006 | US20060182817 Steroidal sapogenins and their derivatives for treating Alzheimer's disease |
| 08/17/2006 | US20060182802 Rapidly disintegrable solid preparation |
| 08/17/2006 | US20060182734 Contacting polysaccharide with disaccharide repeat unit of uronic acid [ alpha -L-iduronic acid or beta -D-glucuronic acid ] linked 1, 4 to alpha -D-hexosamine with mutant heparinase III; sequencing mucopolysaccharides; antitumor, anticarcinogenic and antimetastasis agents; angiogenesis inhibitors |
| 08/17/2006 | CA2639880A1 Anti-diabetic or anti-hypertensive dietary supplement |
| 08/17/2006 | CA2597541A1 Crystal of 4(3h)-quinazolinone derivative |
| 08/16/2006 | EP1690869A1 Peptide inhibiting angiontensin converting enzyme |
| 08/16/2006 | EP1690857A1 Modified-protein formation inhibitor |
| 08/16/2006 | EP1690546A2 Transplants for myocardial scars and method and cellular preparations therefor |
| 08/16/2006 | EP1690538A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor |
| 08/16/2006 | EP1689752A1 Pyrazolopyrimidines |
| 08/16/2006 | EP1689751A1 5,7-diaminopyrazolo¬4,3-d|pyrimidines with pde-5 inhibiting activity |
| 08/16/2006 | EP1689718A1 1-amino-isoquinoline derivatives for the treatment of diseases associated with inappropriate alk5 activity |
| 08/16/2006 | EP1689714A2 Therapeutic use of pyridinium compounds to modulate naadp activity |
| 08/16/2006 | EP1689711A1 Method for producing n- 1-(s)-carbalkoxy-3-phenylpropyl|-s-alanyl-2s, 3ar, 7as-octahydroindol-2-carboxylic acid compounds |
| 08/16/2006 | EP1689710A1 Indole derivatives for use as chemical uncoupler |
| 08/16/2006 | EP1689702A1 Organic compounds |
| 08/16/2006 | EP1689447A2 Gene transfer for regulating smooth muscle tone |
| 08/16/2006 | EP1689441A1 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 08/16/2006 | EP1689424A1 Use of cyclic anabaenopeptin-type peptides for the treatment of a condition wherein inhibition of carboxypeptidase u is beneficial, novel anabaenopeptin derivatives and intermediates thereof |
| 08/16/2006 | EP1689420A1 Use of g-csf for treating ischemia |
| 08/16/2006 | EP1689413A2 Glycerophospholipids containing omega-3 and omega-6 fatty acids |
| 08/16/2006 | EP1689410A2 Prevention and treatment of hypertensive heart diseases by the selective estrogens 8beta-vinyl-estra-1,3,5(10)-trien-3,17beta-diol and 17beta-fluor-9alpha-vinyl-estra-1,3,5(10)-trien-3,16alpha-diol |
| 08/16/2006 | EP1689407A1 Method of treatment of atherosclerosis |
| 08/16/2006 | EP1689393A2 Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors |
| 08/16/2006 | EP1689386A1 Tubular proteinuria as an indicator for elevated cardiovascular risk |
| 08/16/2006 | EP1689384A1 Complexes of cyclic polyaza chelators with cations of alkaline earth metals for enhanced biological activity |
| 08/16/2006 | EP1689381A1 Pharmaceutical composition comprising i.a. vitamin c, magnesium, green tea extract for retarding cardiovascular diseases |
| 08/16/2006 | EP1513835B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/16/2006 | EP1487437B1 Use of selective ep4 receptor agonists for the treatment of diseases |
| 08/16/2006 | EP1478352B1 Pharmaceutical dosage form and method for the production thereof |
| 08/16/2006 | EP1432702B1 Nitrogen-containing heterocyclic compounds and their use as raf inhibitors |
| 08/16/2006 | EP1385578B1 Utilization of rutins and aescins in the treatment of circulatory disturbances of the ear |
| 08/16/2006 | EP1368320B1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
| 08/16/2006 | EP1318991B1 Benzoic acid derivatives and uses thereof |
| 08/16/2006 | EP1259234B1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 08/16/2006 | EP1183020B1 (3-trihalomethylphenoxy) (4-halophenyl) for the treatment of insulin resistance and type 2 diabetes |
| 08/16/2006 | EP1165490B1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 08/16/2006 | EP1137410B1 Novel 4-dedimethyl aminotetracycline derivatives |
| 08/16/2006 | EP1117682B1 Chi-Conotoxin Peptides as INhibitors of Neuronal Amine Transporters |
| 08/16/2006 | EP1058726B1 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | EP0980362B1 Substituted heterocycles and their use in medicaments |
| 08/16/2006 | EP0880523B1 Pyrazolopyrimidines as crf receptor antagonists |
| 08/16/2006 | EP0809655B1 PEPTIDES AND PEPTIDOMIMETICS WITH STRUCTURAL SIMILARITY TO HUMAN p53 THAT ACTIVATE p53 FUNCTION |
| 08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
| 08/16/2006 | CN1820012A Organosilicon compounds and their use |
| 08/16/2006 | CN1819845A Medicinal composition containing NF-kappa B decoy for treating and preventing respiratory diseases and method of using the same |
| 08/16/2006 | CN1819828A Nasal pharmaceutical composition of piribedil |
| 08/16/2006 | CN1819823A Orodispersible pharmaceutical composition of an antithrombotic compound |
| 08/16/2006 | CN1819777A Gnetum extract |
| 08/16/2006 | CN1817884A Pyrimidinone derivatives and 3-keto ester |
| 08/16/2006 | CN1817883A New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound |
| 08/16/2006 | CN1817863A 3-substituted 1,2,3.4-tetrahydro-quinazine derivative, its synthesis and use |
| 08/16/2006 | CN1817854A Amino acids with affinity for the alpha-2-delta protein |
| 08/16/2006 | CN1817365A Injecting Mailuoning, its preparation and quality control thereof |
| 08/16/2006 | CN1817363A Medicine for treating various diseases |
| 08/16/2006 | CN1817362A Chinese medicinal composition for treating heart failure and oral preparation |
| 08/16/2006 | CN1817360A Medicinal composition for treating acute and chronic congestive heart failure, its preparation and use |
| 08/16/2006 | CN1817356A Production of vermilion injection for treating cardiovascular disease |
| 08/16/2006 | CN1817355A Chinese medicinal oral preparation for treating cardiovascular disease and production thereof |
| 08/16/2006 | CN1817354A Injection of manchurian wildginge and astragalus root and its preparing method |